These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33600475)

  • 1. The global procurement landscape of leishmaniasis medicines.
    Choi HL; Jain S; Ruiz Postigo JA; Borisch B; Dagne DA
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009181. PubMed ID: 33600475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study.
    Sunyoto T; Potet J; den Boer M; Ritmeijer K; Postigo JAR; Ravinetto R; Alves F; Picado A; Boelaert M
    BMJ Open; 2019 May; 9(5):e029141. PubMed ID: 31152044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensuring access to essential health products: Lessons from Colombia's leishmaniasis control and elimination initiative.
    Vlassoff C; Giron N; Vera Soto MJ; Maia-Elkhoury ANS; Lal A; Castellanos LG; Almeida G; Lim C
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011752. PubMed ID: 38039275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholder perspectives on the challenges surrounding management and supply of essential medicines.
    Duong MH; Moles RJ; Chaar B; Chen TF
    Int J Clin Pharm; 2019 Oct; 41(5):1210-1219. PubMed ID: 31444686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical procurement among public sector procurers in CARICOM.
    Preston C; King C; Hinds M; Burnett F; Extavour RM
    Rev Panam Salud Publica; 2021; 45():e57. PubMed ID: 34025728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
    Coghlan R; Stephens P; Mwale B; Siyanga M
    Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Landscape analysis of NTD diagnostics and considerations on the development of a strategy for regulatory pathways.
    Choi HL; Ducker C; Braniff S; Argaw D; Solomon AW; Borisch B; Mubangizi D
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010597. PubMed ID: 35788571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of medicines - Indian perspective!
    Mohanta GP; Manna PK
    Int J Risk Saf Med; 2015; 27 Suppl 1():S47-8. PubMed ID: 26639706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pricing of drugs and donations: options for sustainable equity pricing.
    Pérez-Casas C; Herranz E; Ford N
    Trop Med Int Health; 2001 Nov; 6(11):960-4. PubMed ID: 11703854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for understanding generic procurement of HIV medicines by developing countries with patent protection.
    Beall RF; Attaran A
    Soc Sci Med; 2017 Jul; 185():118-126. PubMed ID: 28578209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local causes of essential medicines shortages from the perspective of supply chain professionals in Saudi Arabia.
    AlRuthia Y; Mohammed Almutiri N; Musa Almutairi R; Almohammed O; Alhamdan H; Ali El-Haddad S; Abdu Asiri Y
    Saudi Pharm J; 2023 Jun; 31(6):948-954. PubMed ID: 37234344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: a patent landscape.
    Machado-Silva A; Guimarães PP; Tavares CA; Sinisterra RD
    Expert Opin Ther Pat; 2015 Mar; 25(3):247-60. PubMed ID: 25530084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential medicine shortages, procurement process and supplier response: A normative study across Indian states.
    Chebolu-Subramanian V; Sundarraj RP
    Soc Sci Med; 2021 Jun; 278():113926. PubMed ID: 33892243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmaniasis.
    Burza S; Croft SL; Boelaert M
    Lancet; 2018 Sep; 392(10151):951-970. PubMed ID: 30126638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.
    't Hoen EFM; Kujinga T; Boulet P
    J Pharm Policy Pract; 2018; 11():31. PubMed ID: 30524732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The logical underpinnings and benefits of pooled pharmaceutical procurement: a pragmatic role for our public institutions?
    Huff-Rousselle M
    Soc Sci Med; 2012 Nov; 75(9):1572-80. PubMed ID: 22835922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDR collaboration with the pharmaceutical industry.
    Gutteridge WE
    Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S21-5. PubMed ID: 16730039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to essential medicines for sexual and reproductive health care: the role of the pharmaceutical industry and international regulation.
    Cottingham J; Berer M
    Reprod Health Matters; 2011 Nov; 19(38):69-84. PubMed ID: 22118143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procurement process and shortages of essential medicines in public health facilities: A qualitative study from Nepal.
    Adhikari B; Ranabhat K; Khanal P; Poudel M; Marahatta SB; Khanal S; Paudyal V; Shrestha S
    PLOS Glob Public Health; 2024; 4(5):e0003128. PubMed ID: 38696399
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.